Lobbying client
FIGHT TO LIVE
Community for change at the FDA to transform Cancer and Terminal Diseases
Filings
6
Filed by
1
Reported in-house
—
Reported by firms
—
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2013 to 2014
Filings
6 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
3rd Quarter - Termination (No Activity) 3rd Quarter 2014
|
TAYLOR, SYLLA & AGIN, LLP | — reported |
|
2nd Quarter - Report (No Activity) 2nd Quarter 2014
|
TAYLOR, SYLLA & AGIN, LLP | — reported |
|
1st Quarter - Report (No Activity) 1st Quarter 2014
|
TAYLOR, SYLLA & AGIN, LLP | — reported |
|
4th Quarter - Report (No Activity) 4th Quarter 2013
|
TAYLOR, SYLLA & AGIN, LLP | — reported |
|
3rd Quarter - Report 3rd Quarter 2013
|
TAYLOR, SYLLA & AGIN, LLP | — reported |
|
Registration 3rd Quarter 2013
|
TAYLOR, SYLLA & AGIN, LLP | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| TAYLOR, SYLLA & AGIN, LLP | 5 | — |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 2 |
| Medical/Disease Research/Clinical Labs | MED | 1 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
| Bill | Congress | Times named |
|---|---|---|
| H.R. 2090 | 113th | 1 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.